Super-resolution microscopy reveals that Na+/K+-ATPase signaling protects against glucose-induced apoptosis by

Kristoffer Bernhem1, Jacopo M Fontana1, Daniel Svensson2

  • 1Science for Life Laboratory, Department of Applied Physics, Royal Institute of Technology, Solna, Sweden.

Cell Death & Disease
|July 28, 2021
PubMed

Insights

Ouabain, a cardiotonic steroid, shows potential as an early-stage anti-apoptotic drug. It protects renal epithelial cells from high glucose-induced apoptosis by inhibiting key protein activation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Nephrology

Background:

  • Apoptosis contributes to chronic disease progression, including neurodegenerative and diabetic kidney diseases.
  • Current treatments lack effective early-stage anti-apoptotic interventions.
  • The Na +, K +, -ATPase protein has signaling roles beyond ion transport, activated by ouabain.

Purpose of the Study:

  • To investigate the early anti-apoptotic effects of ouabain in renal epithelial cells.
  • To elucidate the molecular mechanisms underlying ouabain's protective action against high glucose-induced apoptosis.

Main Methods:

  • Primary rat renal epithelial cells were exposed to high glucose (20 mM) to induce apoptosis.
  • Super-resolution microscopy was used to visualize early apoptotic events.
  • The effects of 10 nM ouabain on apoptotic pathway proteins (Bad, Bax) and kinases were analyzed.

Main Results:

  • Ouabain treatment inhibited the activation and mitochondrial translocation of the BH3-only protein Bad.
  • This inhibition occurred prior to the recruitment of the pro-apoptotic protein Bax to mitochondria.
  • Two ouabain-regulated, Akt-activating Ca 2+, /calmodulin-dependent kinases were identified as crucial for the anti-apoptotic effect.

Conclusions:

  • Ouabain demonstrates potential as an early-stage anti-apoptotic therapeutic agent.
  • It interferes with the initial steps of the apoptotic cascade, specifically Bad activation.
  • Further research into ouabain for diabetic kidney disease and other apoptosis-related chronic conditions is warranted.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.7K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.4K
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
33.3K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.4K
Secondary Active Transport01:32

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
8.5K